Social aspects of genetic testing for factor V leiden mutation in healthy individuals and their importance for daily practice

被引:35
作者
Bank, I
Scavenius, MPRB
Büller, HR
Middeldorp, S
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands
关键词
qualitative study; screening; factor V leiden; mutation; social aspects; stigmatisation; guideline;
D O I
10.1016/j.thromres.2004.02.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To explore social aspects of asymptomatic carriership of factor V Leiden mutation (FVL) and how carriers have experienced procedure of screening for FVL, we have performed a qualitative study using semi-structured interviews. Seventeen carriers of FVL without history of venous thromboembolism (VTE) were interviewed. Carriership of FVL has the potential to influence daily life by inducing concerns, stigmatisation and problems with insurances. Furthermore, proper procedure of screening is important because carriers have many questions concerning progeny, risk factors for VTE and preventive measures. Both health worker and the individual to be screened for FVL need to be fully aware of the possible consequences of screening and the fact that proper screening comprises more than only the collection of a blood sample or explaining the amount of risk for VTE induced by a genetic defect. Any guideline to be developed for the screening for FVL should take this into account too. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 22 条
[1]  
BILLINGS PR, 1992, AM J HUM GENET, V50, P476
[2]  
CROYLE R, 1995, PSYCHOSOCIAL EFFECTS
[3]  
Croyle RT, 1997, CANCER, V80, P569, DOI 10.1002/(SICI)1097-0142(19970801)80:3+<569::AID-CNCR6>3.0.CO
[4]  
2-4
[5]   How to read a paper - Papers that go beyond numbers (qualitative research) [J].
Greenhalgh, T ;
Taylor, R .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7110) :740-743
[6]  
Hardon A. P., 1994, APPL HLTH RES MANUAL
[7]   Mortality and causes of death in families with the factor V Leiden mutation (Resistance to activated protein C) [J].
Hille, ETM ;
Westendorp, RGJ ;
Vandenbroucke, JP ;
Rosendaal, FR .
BLOOD, 1997, 89 (06) :1963-1967
[8]   STIGMATIZATION OF CARRIER STATUS - SOCIAL IMPLICATIONS OF HETEROZYGOTE GENETIC SCREENING PROGRAMS [J].
KENEN, RH ;
SCHMIDT, RM .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1978, 68 (11) :1116-1120
[9]   Genetic and biochemical screening for endocrine disease: II. Ethical issues [J].
Kinder, BK .
WORLD JOURNAL OF SURGERY, 1998, 22 (12) :1208-1211
[10]   Genetic discrimination: Perspectives of consumers [J].
Lapham, EV ;
Kozma, C ;
Weiss, JO .
SCIENCE, 1996, 274 (5287) :621-624